Cambridge Heart CH 2000 Cardiac Diagnostic System
510(k) K981697
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK981697 | Date14 Oct 1998 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DPS
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.2340
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 25 Sep 2026
The Cambridge Heart CH 2000 Cardiac Diagnostic System is a device that records electrocardiograms (ECG) and vector cardiograms. It processes cardiac signals to detect alternans and provides output to healthcare providers for diagnostic or prognostic evaluation.
The system is used at rest or during stress testing and is operated by or under the direction of a physician in clinical settings. It received FDA 510(k) clearance under K981697 and is classified under product code DPS with advisory committee review in cardiovascular (CV) devices.
Other devices from Cambridge Heart, Inc.
Questions
AI-generated answers, 25 Sep 2026
What is the Cambridge Heart CH 2000 Cardiac Diagnostic System used for?
The Cambridge Heart CH 2000 Cardiac Diagnostic System records electrocardiograms (ECG) and vector cardiograms, processes cardiac signals to detect alternans, and provides output to healthcare providers for diagnostic or prognostic evaluation. It is used at rest or during stress testing under physician direction in clinical settings.
How is the Cambridge Heart CH 2000 Cardiac Diagnostic System supplied and operated?
The system is operated by or under the direction of a physician in clinical settings. It is used at rest or during stress testing to record and process cardiac signals for alternans detection, providing diagnostic or prognostic output to healthcare providers.
What regulatory pathway was used for the Cambridge Heart CH 2000 Cardiac Diagnostic System?
The Cambridge Heart CH 2000 Cardiac Diagnostic System received FDA 510(k) clearance under K981697, with a decision of substantially equivalent (SESE) on October 14, 1998, following a traditional clearance type and advisory committee review in cardiovascular devices.